Tina Reed - Axios
This content serves as a professional profile for Tina Reed, a senior health care reporter at Axios. It highlights her role as the author of the daily 'Axios Vitals' newsletter, which provides in-depth coverage of health care politics, policy, and business developments. The page aggregates her recent journalistic output, featuring articles on significant current events such as the Trump administration's nomination of a former deputy surgeon general to lead the Centers for Disease Control and Prevention (CDC). Additionally, it covers legal challenges facing state efforts to regulate Pharmacy Benefit Managers (PBMs) and public health concerns regarding bird flu outbreaks in Washington state. The profile also lists recent newsletter editions discussing topics like RFK Jr.'s political activities, direct-to-consumer drug markets, and pharmaceutical tariff pressures. This collection demonstrates Reed's focus on the intersection of government policy, corporate business strategies, and public health infrastructure within the United States healthcare system.
Wire timeline
Tina Reed - Axios
This content serves as a professional profile for Tina Reed, a senior health care reporter at Axios. It highlights her role as the author of the daily 'Axios Vitals' newsletter, which provides in-depth coverage of health care politics, policy, and business developments. The page aggregates her recent journalistic output, featuring articles on significant current events such as the Trump administration's nomination of a former deputy surgeon general to lead the Centers for Disease Control and Prevention (CDC). Additionally, it covers legal challenges facing state efforts to regulate Pharmacy Benefit Managers (PBMs) and public health concerns regarding bird flu outbreaks in Washington state. The profile also lists recent newsletter editions discussing topics like RFK Jr.'s political activities, direct-to-consumer drug markets, and pharmaceutical tariff pressures. This collection demonstrates Reed's focus on the intersection of government policy, corporate business strategies, and public health infrastructure within the United States healthcare system.
axios